120 related articles for article (PubMed ID: 38736717)
1. Site-agnostic PARP-inhibitor maintenance therapy of advanced stage
Tostrud LJ; Somasegar S; Renz M
Gynecol Oncol Rep; 2024 Jun; 53():101406. PubMed ID: 38736717
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing.
Garg S; Nagaria TS; Clarke B; Freedman O; Khan Z; Schwock J; Bernardini MQ; Oza AM; Han K; Smith AC; Stockley TL; Rouzbahman M
Mod Pathol; 2019 Dec; 32(12):1823-1833. PubMed ID: 31308508
[TBL] [Abstract][Full Text] [Related]
3. Durable clinical benefit from PARP inhibition in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report.
Rubinson D; Wolpin BM; Warsofsky IS; Ryan DP; Perez K; Rahma O; Singh H; Yurgelun MB; Shapiro GI; Aguirre AJ; D'Andrea AD; Cleary JM
J Gastrointest Oncol; 2021 Dec; 12(6):3133-3140. PubMed ID: 35070436
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
[TBL] [Abstract][Full Text] [Related]
5. TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of
Ben Khaled N; Hammer K; Ye L; Alnatsha A; Widholz SA; Piseddu I; Sirtl S; Schneider J; Munker S; Mahajan UM; Montero JJ; Griger J; Mayerle J; Reiter FP; De Toni EN
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358659
[TBL] [Abstract][Full Text] [Related]
6. Huge Ovarian Tumor: An Unusual Presentation of Gastric-Type Endocervical Adenocarcinoma.
Park M; Lee E
Case Rep Oncol; 2022; 15(3):1009-1013. PubMed ID: 36636685
[TBL] [Abstract][Full Text] [Related]
7. BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
Petrelli A; Rizzolio S; Pietrantonio F; Bellomo SE; Benelli M; De Cecco L; Romagnoli D; Berrino E; Orrù C; Ribisi S; Moya-Rull D; Migliore C; Conticelli D; Maina IM; Puliga E; Serra V; Pellegrino B; Llop-Guevara A; Musolino A; Siena S; Sartore-Bianchi A; Prisciandaro M; Morano F; Antista M; Fumagalli U; De Manzoni G; Degiuli M; Baiocchi GL; Amisano MF; Ferrero A; Marchiò C; Corso S; Giordano S
Cancer Res; 2023 May; 83(10):1699-1710. PubMed ID: 37129948
[TBL] [Abstract][Full Text] [Related]
8. Complete Response of a Mutated BRCA2 Metastatic Clear Cell Endometrial Adenocarcinoma to the Poly (ADP ribose) Polymerase (PARP) Inhibitor Olaparib.
Anzellini D; Arcangeli G; Del Bianco S
Cancer Diagn Progn; 2022; 2(1):84-86. PubMed ID: 35400012
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study.
Joris S; Denys H; Collignon J; Rasschaert M; T'Kint de Roodenbeke D; Duhoux FP; Canon JL; Tejpar S; Mebis J; Decoster L; Aftimos P; De Grève J
ESMO Open; 2023 Dec; 8(6):102041. PubMed ID: 37852034
[TBL] [Abstract][Full Text] [Related]
10. A Rare Case of Endocervical Adenocarcinoma of Gastric Type.
Mekheal E; Kania BE; Kapoor A; Kumar V; Maroules M
Cureus; 2022 Dec; 14(12):e33059. PubMed ID: 36721594
[TBL] [Abstract][Full Text] [Related]
11. Gastric-type adenocarcinoma in situ of uterine cervix: cytological and histopathological features of two cases.
Yuan CT; Lin MC; Kuo KT; Wang TH; Mao TL
Virchows Arch; 2016 Sep; 469(3):351-6. PubMed ID: 27334141
[TBL] [Abstract][Full Text] [Related]
12. Response to olaparib in metastatic lung adenocarcinoma with germline BRCA2 mutation: a case report.
Wu C; Fan M; Hu Y
Anticancer Drugs; 2022 Jan; 33(1):e734-e737. PubMed ID: 34387603
[TBL] [Abstract][Full Text] [Related]
13. Trefoil factor family 2 protein: a potential immunohistochemical marker for aiding diagnosis of lobular endocervical glandular hyperplasia and gastric-type adenocarcinoma of the uterine cervix.
Asaka S; Nakajima T; Momose M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2019 Jan; 474(1):79-86. PubMed ID: 30324235
[TBL] [Abstract][Full Text] [Related]
14. Lobular Endocervical Glandular Hyperplasia, a mimicker and potential pitfall for HPV-independent well differentiated Gastric-type Endocervical Adenocarcinoma: Case report and literature review focusing on histology, immunophenotype, and molecular findings.
Molero A; Parra A; Blanco I; Ascensión A; Ortega P
SAGE Open Med Case Rep; 2023; 11():2050313X231186210. PubMed ID: 37434896
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of immunophenotypic characterization of endocervical adenocarcinoma using CLDN18, CDH17, and PAX8 in association with HPV status.
Asaka S; Nakajima T; Ida K; Asaka R; Kobayashi C; Ito M; Miyamoto T; Uehara T; Ota H
Virchows Arch; 2022 Feb; 480(2):269-280. PubMed ID: 34581850
[TBL] [Abstract][Full Text] [Related]
16. Gastric-type endocervical adenocarcinoma with uterine corpus involvement mimicking primary endometrial carcinoma.
Kamiya A; Ikura Y; Iizuka N; Yokokawa T; Kato H; Oishi T
J Obstet Gynaecol Res; 2019 Jul; 45(7):1414-1417. PubMed ID: 31012190
[TBL] [Abstract][Full Text] [Related]
17. PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions.
Konecny GE; Kristeleit RS
Br J Cancer; 2016 Nov; 115(10):1157-1173. PubMed ID: 27736844
[TBL] [Abstract][Full Text] [Related]
18. A rare case of gastric-type mucinous endocervical adenocarcinoma in a 59-year-old woman.
Mulita F; Iliopoulos F; Kehagias I
Prz Menopauzalny; 2020 Sep; 19(3):147-150. PubMed ID: 33100952
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic relevance of a
Sigurdson S; Marom EM; Rimner A; Shepherd A; Szolkowska M; Roden AC; Marino M; Tomiyama N; Ball D; Falkson C; Rajan A
Mediastinum; 2022; 6():40. PubMed ID: 36582974
[TBL] [Abstract][Full Text] [Related]
20. Gastric type mucinous endocervical adenocarcinoma of the uterine cervix: very rare and interesting case.
Park CM; Koh HM; Park S; Kang HS; Shim SS; Kim SY
Obstet Gynecol Sci; 2018 Jan; 61(1):165-169. PubMed ID: 29372165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
